Sanofi

News

Red blood cells moving in blood vessels with depth of field.

Sanofi trumpets data with haemophilia treatment duo at ISTH

Sanofi R&D in its core haemophilia category is advancing on three fronts – engineered proteins, RNA interference drugs and gene therapies – and highlighted results in two of those at th

News

Sanofi makes low-cost medicines pledge for low-income countr...

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the

News

Liver injuries prompt clinical hold on Sanofi BTK drug

One of the main assets of Sanofi's $3.7 billion buyout of Principia Biopharma has run into trouble, after the FDA placed it on partial clinical hold while a safety signal is investigated.

News

Sanofi extends Health2Sync digital diabetes partnership to J...

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets.

News

Celebrations for ASMD community as EU clears Sanofi's Xenpoz...

Sanofi has claimed approval in the EU for Xenpozyme as a treatment for acid sphingomyelinase deficiency (ASMD) – which becomes the first and only treatment option for patients with the rare

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

Sanofi trumpets data with haemophilia treatment duo at ISTH

Sanofi makes low-cost medicines pledge for low-income countr...

Liver injuries prompt clinical hold on Sanofi BTK drug

Sanofi extends Health2Sync digital diabetes partnership to J...

Celebrations for ASMD community as EU clears Sanofi's Xenpoz...

Takeda bolsters data for dengue jab as regulatory reviews ro...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Sanofi

Editor's Picks